The vigorous controversy about the recent recommendation of the US Preventive Services Task Force (USPSTF) [1] against routine screening mammography for healthy, low-risk women aged 40 to 50 years has demonstrated our broad national consensus about the value of preventive medicine in general and breast cancer screening specifically. Nonetheless, many of the recent dissenting commentaries on this issue from concerned professionals [2], professional organizations [3], patients and their loved ones, and politicians have been narrowly focused and have tended to overlook important considerations.
展开▼
